3,215.67
+58.89
+(1.87%)
At close: July 31 at 8:25:28 AM CST
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 15 | 15 | 18 | 18 |
| Avg. Estimate | 366.76M | 432.89M | 1.54B | 1.7B |
| Low Estimate | 365.9M | 427.28M | 1.54B | 1.67B |
| High Estimate | 367.98M | 438.1M | 1.55B | 1.75B |
| Year Ago Sales | 326.36M | 401.28M | 1.4B | 1.54B |
| Sales Growth (year/est) | 12.38% | 7.88% | 10.13% | 9.88% |
EPS Trend
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| PCTY.MX | -- | -- | -- | -- |
| S&P 500 | 9.34% | 11.29% | 14.06% | 13.55% |
Upgrades & Downgrades
| Upgrade | Citigroup: Neutral to Buy | 1/16/2025 |
| Reiterates | Needham: Buy to Buy | 1/15/2025 |
| Maintains | TD Cowen: Buy to Buy | 1/6/2025 |
| Maintains | Mizuho: Neutral to Neutral | 12/13/2024 |
| Maintains | BMO Capital: Outperform to Outperform | 12/12/2024 |
| Maintains | Jefferies: Buy to Buy | 12/9/2024 |